About Enhancer
| Enhancer ID: | E_00162 |
| Species: | Homo sapiens |
| Position : | chr9:22102683-22103683   |
| Year: | 2021 |
| Title: | A Functional Variant on 9p213 Related to Glioma Risk Affects Enhancer Activity and Modulates Expression of CDKN2B-AS1 |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cervical cancer |
| PMID: | 34153138 |
| MONDO: | MONDO:0001156 |
| Tissue: | Cervical Epithelium |
| Tissue Ontology ID: | UBERON:0000002 |
| Cell Source: | HeLa |
| CVCL ID: | CVCL_0030 |
| Cell Type: | cervical adenocarcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq, Hi-C |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, RT-RT-qPCR |
About Target Gene
| Target gene : | CDKN2B-AS1 |
About TF
| TF name : |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Expression of Target Genes for the Enhancer